JP2006513221A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006513221A5 JP2006513221A5 JP2004563939A JP2004563939A JP2006513221A5 JP 2006513221 A5 JP2006513221 A5 JP 2006513221A5 JP 2004563939 A JP2004563939 A JP 2004563939A JP 2004563939 A JP2004563939 A JP 2004563939A JP 2006513221 A5 JP2006513221 A5 JP 2006513221A5
- Authority
- JP
- Japan
- Prior art keywords
- alkoxy
- hydroxy
- alkyl
- halogen
- aryl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 0 *c1ccc(C=Cc2n[n]cc2)cc1 Chemical compound *c1ccc(C=Cc2n[n]cc2)cc1 0.000 description 10
- FFTZWJNNDVASCO-HXGSSHHBSA-N C(/C=C/c1ccccc1)=C/c1n[nH]cc1 Chemical compound C(/C=C/c1ccccc1)=C/c1n[nH]cc1 FFTZWJNNDVASCO-HXGSSHHBSA-N 0.000 description 1
- YLKIXQUPYKAWAB-UHFFFAOYSA-N C(c1n[nH]cc1)=C/c1c(-c2ccccc2)nc2[s]cc[n]12 Chemical compound C(c1n[nH]cc1)=C/c1c(-c2ccccc2)nc2[s]cc[n]12 YLKIXQUPYKAWAB-UHFFFAOYSA-N 0.000 description 1
- PJLORFGDSVWAEC-UHFFFAOYSA-N C(c1n[nH]cc1)=C/c1ccc[o]1 Chemical compound C(c1n[nH]cc1)=C/c1ccc[o]1 PJLORFGDSVWAEC-UHFFFAOYSA-N 0.000 description 1
- FOHWAQGURRYJFK-UHFFFAOYSA-N C(c1n[nH]cc1)=C/c1ccc[s]1 Chemical compound C(c1n[nH]cc1)=C/c1ccc[s]1 FOHWAQGURRYJFK-UHFFFAOYSA-N 0.000 description 1
- NFLQSIIRRGMWIY-UHFFFAOYSA-N C(c1n[nH]cc1)=C/c1ccccc1 Chemical compound C(c1n[nH]cc1)=C/c1ccccc1 NFLQSIIRRGMWIY-UHFFFAOYSA-N 0.000 description 1
- NABHSXYZOUDRHL-NNIYNVSXSA-N C/C(/C(C(C1)C=CC1/C=C/c1ccc[o]1)=O)=C\C=C/[U] Chemical compound C/C(/C(C(C1)C=CC1/C=C/c1ccc[o]1)=O)=C\C=C/[U] NABHSXYZOUDRHL-NNIYNVSXSA-N 0.000 description 1
- ASEQLAXHASWYIT-OWOJBTEDSA-N C1C(/C=C/c2n[nH]cc2)N=NC1 Chemical compound C1C(/C=C/c2n[nH]cc2)N=NC1 ASEQLAXHASWYIT-OWOJBTEDSA-N 0.000 description 1
- GVKUQDGDOVVLFW-XJMFGXJGSA-N CC(C1N=C(/C=C/C2=CC=C[C@H]2C)C=C1)c1ccc[s]1 Chemical compound CC(C1N=C(/C=C/C2=CC=C[C@H]2C)C=C1)c1ccc[s]1 GVKUQDGDOVVLFW-XJMFGXJGSA-N 0.000 description 1
- IEMMBWWQXVXBEU-UHFFFAOYSA-N CC(c1ccc[o]1)=O Chemical compound CC(c1ccc[o]1)=O IEMMBWWQXVXBEU-UHFFFAOYSA-N 0.000 description 1
- XDOKUIJGTVJMBQ-VOTSOKGWSA-N CC1(C)C(/C=C/c2n[nH]cc2)C(C)=CCC1 Chemical compound CC1(C)C(/C=C/c2n[nH]cc2)C(C)=CCC1 XDOKUIJGTVJMBQ-VOTSOKGWSA-N 0.000 description 1
- PFBGETQWUQTYMC-QSUIBIRJSA-N C[C@H](/C=C\C(/C=C/C1OCCC1)=N)C(Cc(cc1)ccc1Cl)=O Chemical compound C[C@H](/C=C\C(/C=C/C1OCCC1)=N)C(Cc(cc1)ccc1Cl)=O PFBGETQWUQTYMC-QSUIBIRJSA-N 0.000 description 1
- LZWJXTNHDXYVTA-NSCUHMNNSA-N Cc1n[o]c(/C=C/c2n[nH]cc2)c1N Chemical compound Cc1n[o]c(/C=C/c2n[nH]cc2)c1N LZWJXTNHDXYVTA-NSCUHMNNSA-N 0.000 description 1
- WTLCERBYPIMJNW-SNAWJCMRSA-N Clc1cccc(Cl)c1/C=C/c1n[nH]cc1 Chemical compound Clc1cccc(Cl)c1/C=C/c1n[nH]cc1 WTLCERBYPIMJNW-SNAWJCMRSA-N 0.000 description 1
- KALNHHPDFLFWRP-WEVVVXLNSA-N NOc1ccc(CC(C2C=CC(/C=C/C3CCCC3)=NC2)=O)cc1 Chemical compound NOc1ccc(CC(C2C=CC(/C=C/C3CCCC3)=NC2)=O)cc1 KALNHHPDFLFWRP-WEVVVXLNSA-N 0.000 description 1
- VLZMIVFQQBXBTQ-VOTSOKGWSA-N NOc1ccc(CC(N2C=CC(/C=C/c3ccccc3)=CC2)=O)cc1 Chemical compound NOc1ccc(CC(N2C=CC(/C=C/c3ccccc3)=CC2)=O)cc1 VLZMIVFQQBXBTQ-VOTSOKGWSA-N 0.000 description 1
- YKFMMTOUODEEER-ONEGZZNKSA-N N[n]1c(/C=C/c2n[nH]cc2)ccc1 Chemical compound N[n]1c(/C=C/c2n[nH]cc2)ccc1 YKFMMTOUODEEER-ONEGZZNKSA-N 0.000 description 1
- MSNGHWNJGROJSW-SOFGYWHQSA-N O=C(C1C=C(/C=C/C2OC=CC2)C=C1)c1ccc[s]1 Chemical compound O=C(C1C=C(/C=C/C2OC=CC2)C=C1)c1ccc[s]1 MSNGHWNJGROJSW-SOFGYWHQSA-N 0.000 description 1
- NVHPHISBYYDWBI-JXMROGBWSA-N O=C(C1C=CC(/C=C/c2ccc[o]2)=CC1)c1ccc[o]1 Chemical compound O=C(C1C=CC(/C=C/c2ccc[o]2)=CC1)c1ccc[o]1 NVHPHISBYYDWBI-JXMROGBWSA-N 0.000 description 1
- UNHJCDSXJJHSQQ-GQCTYLIASA-N O=C(C1C=CC(/C=C/c2ccc[o]2)=CNC1)C1=CSCC1 Chemical compound O=C(C1C=CC(/C=C/c2ccc[o]2)=CNC1)C1=CSCC1 UNHJCDSXJJHSQQ-GQCTYLIASA-N 0.000 description 1
- GKHHPICNPBDGTO-VOTSOKGWSA-N O=C(c1c[s]cc1)N(C1)C=CC1/C=C/c1ccccc1 Chemical compound O=C(c1c[s]cc1)N(C1)C=CC1/C=C/c1ccccc1 GKHHPICNPBDGTO-VOTSOKGWSA-N 0.000 description 1
- HESBHQPOAFXLSA-AATRIKPKSA-N O=Cc1ccc(/C=C/c2n[nH]cc2)cc1 Chemical compound O=Cc1ccc(/C=C/c2n[nH]cc2)cc1 HESBHQPOAFXLSA-AATRIKPKSA-N 0.000 description 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US43553302P | 2002-12-21 | 2002-12-21 | |
| US60/435,533 | 2002-12-21 | ||
| US10/740,708 US7192976B2 (en) | 2002-12-21 | 2003-12-18 | Small molecule modulators of hepatocyte growth factor (scatter factor) activity |
| US10/740,708 | 2003-12-18 | ||
| PCT/US2003/040917 WO2004058721A2 (en) | 2002-12-21 | 2003-12-19 | Pyrazole derivatives modulators of hepatocyte growth factor (scatter factor) activity |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010186703A Division JP5755417B2 (ja) | 2002-12-21 | 2010-08-23 | 肝細胞増殖因子（分散因子）活性のピラゾール誘導体モジュレーター |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2006513221A JP2006513221A (ja) | 2006-04-20 |
| JP2006513221A5 true JP2006513221A5 (enExample) | 2007-02-15 |
| JP5160019B2 JP5160019B2 (ja) | 2013-03-13 |
Family
ID=32685400
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004563939A Expired - Fee Related JP5160019B2 (ja) | 2002-12-21 | 2003-12-19 | 肝細胞増殖因子（分散因子）活性のピラゾール誘導体モジュレーター |
| JP2010186703A Expired - Fee Related JP5755417B2 (ja) | 2002-12-21 | 2010-08-23 | 肝細胞増殖因子（分散因子）活性のピラゾール誘導体モジュレーター |
| JP2015016424A Pending JP2015078246A (ja) | 2002-12-21 | 2015-01-30 | 肝細胞増殖因子（分散因子）活性のピラゾール誘導体モジュレーター |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010186703A Expired - Fee Related JP5755417B2 (ja) | 2002-12-21 | 2010-08-23 | 肝細胞増殖因子（分散因子）活性のピラゾール誘導体モジュレーター |
| JP2015016424A Pending JP2015078246A (ja) | 2002-12-21 | 2015-01-30 | 肝細胞増殖因子（分散因子）活性のピラゾール誘導体モジュレーター |
Country Status (10)
| Country | Link |
|---|---|
| US (6) | US7192976B2 (enExample) |
| EP (2) | EP1572199B1 (enExample) |
| JP (3) | JP5160019B2 (enExample) |
| CN (1) | CN1747730B (enExample) |
| AU (1) | AU2003301224C1 (enExample) |
| CA (1) | CA2511199C (enExample) |
| DK (2) | DK2292227T3 (enExample) |
| HU (1) | HUE030700T2 (enExample) |
| IL (1) | IL169316A (enExample) |
| WO (1) | WO2004058721A2 (enExample) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7192976B2 (en) * | 2002-12-21 | 2007-03-20 | Angion Biomedica Corporation | Small molecule modulators of hepatocyte growth factor (scatter factor) activity |
| US20110230407A1 (en) * | 2005-03-14 | 2011-09-22 | Alexander Yuzhakov | Hepatocyte growth factor pathway activators in demyelinating diseases and central nervous system trauma |
| US7879898B1 (en) | 2006-02-14 | 2011-02-01 | Angion Biomedica Corp. | Hepatocyte growth factor pathway activators in chronic obstructive pulmonary disease |
| US8772326B2 (en) | 2008-07-10 | 2014-07-08 | Anigion Biomedica Corp. | Methods and compositions of small molecule modulators of hepatocyte growth factor (scatter factor) activity |
| WO2010068287A2 (en) * | 2008-12-11 | 2010-06-17 | Angion Biomedica Corp. | Small molecule modulators of hepatocyte growth factor (scatter factor) activity |
| WO2011006072A2 (en) * | 2009-07-10 | 2011-01-13 | Northwestern University | Cardioprotective role of hepatic cells and hepatocyte secretory factors in myocardial ischemia |
| US20120190668A1 (en) * | 2009-08-12 | 2012-07-26 | Oehlen Lambertus J W M | Enhancement of cellular transplantation using small moleucle modulators of hepatocyte growth factor (scatter factor) activity |
| JP6155187B2 (ja) | 2010-03-30 | 2017-06-28 | ヴァーセオン コーポレイション | トロンビンの阻害剤としての多置換芳香族化合物 |
| AU2011312333A1 (en) * | 2010-10-05 | 2013-05-02 | Angion Biomedica Corp. | Methods of use of small molecule modulators of hepatocyte growth factor (scatter factor) activity |
| JP6173298B2 (ja) * | 2011-04-02 | 2017-08-02 | ワシントン ステート ユニバーシティ | 治療薬としての肝細胞増殖因子模倣体 |
| WO2012151349A1 (en) | 2011-05-03 | 2012-11-08 | Liu Shu Q | Neuroprotection by hepatic cells and hepatocyte secretory factors |
| UY34200A (es) * | 2011-07-21 | 2013-02-28 | Bayer Ip Gmbh | 3-(fluorovinil)pirazoles y su uso |
| ES2791749T3 (es) | 2013-03-15 | 2020-11-05 | Verseon Corp | Halogenopirazoles como inhibidores de la trombina |
| WO2014145986A1 (en) | 2013-03-15 | 2014-09-18 | Verseon, Inc. | Multisubstituted aromatic compounds as serine protease inhibitors |
| KR20170048410A (ko) | 2014-09-17 | 2017-05-08 | 베르선 코포레이션 | 세린 프로테아제 저해제로서의 피라졸릴-치환된 피리돈 화합물 |
| AU2016224974B2 (en) | 2015-02-27 | 2019-09-26 | Verseon Corporation | Substituted pyrazole compounds as serine protease inhibitors |
| CN114026085A (zh) | 2019-04-11 | 2022-02-08 | 安吉昂生物医药公司 | (e)-3-[2-(2-噻吩基)乙烯基]-1h-吡唑的固体形式 |
| EP4051271A4 (en) * | 2019-10-31 | 2023-11-29 | Angion Biomedica Corp. | IMPROVEMENT IN KIDNEY FUNCTION AFTER KIDNEY TRANSPLANT |
| WO2021183774A1 (en) * | 2020-03-12 | 2021-09-16 | Angion Biomedica Corp. | Treating acute respiratory distress |
| WO2022081703A2 (en) * | 2020-10-14 | 2022-04-21 | Angion Biomedica Corp. | Preparation of terevalefim and formulations thereof |
| WO2022094400A1 (en) * | 2020-11-02 | 2022-05-05 | Athira Pharma, Inc. | Bicyclic compounds and uses thereof for the treatment of diseases |
| WO2022217070A1 (en) * | 2021-04-09 | 2022-10-13 | Angion Biomedica Corp. | Hgf/sf mimetic compounds |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE138770C (enExample) * | ||||
| JPS48713Y1 (enExample) | 1967-12-19 | 1973-01-09 | ||
| JPS48713U (enExample) | 1971-05-22 | 1973-01-08 | ||
| DD138770A1 (de) * | 1978-09-20 | 1979-11-21 | Juergen Liebscher | Verfahren zur herstellung von 5-styryl-pyrazolen und ihren vinylogen |
| JPH02193994A (ja) | 1989-01-23 | 1990-07-31 | Kyowa Hakko Kogyo Co Ltd | ピリダジノン誘導体 |
| FR2669633B1 (fr) * | 1990-11-23 | 1993-01-22 | Adir | Nouveaux derives de la benzoselenazolinone, leur procede de preparation et les compositions pharmaceutiques qui les contiennent. |
| US5837676A (en) * | 1993-10-18 | 1998-11-17 | Long Island Jewish Medical Center | Use of scatter factor to enhance angiogenesis |
| US6498144B1 (en) * | 1993-10-18 | 2002-12-24 | North Shore - Long Island Jewish Research Institute | Use of scatter factor to enhance angiogenesis |
| US5476076A (en) * | 1994-12-06 | 1995-12-19 | Zhou; Zhishan | Internal combustion piston engine utilizing interference movable fit technology |
| JPH11288112A (ja) | 1998-04-06 | 1999-10-19 | Mitsubishi Paper Mills Ltd | 電子写真感光体 |
| PE20010306A1 (es) | 1999-07-02 | 2001-03-29 | Agouron Pharma | Compuestos de indazol y composiciones farmaceuticas que los contienen utiles para la inhibicion de proteina kinasa |
| AU1598801A (en) * | 1999-11-09 | 2001-06-06 | Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The | HGF-SF monoclonal antibody combinations |
| AU7785401A (en) | 2000-06-29 | 2002-01-14 | Long Island Jewish Res Inst | Modulators of cellular proliferation and angiogenesis, methods for use and identification thereof |
| US6589997B2 (en) * | 2001-06-29 | 2003-07-08 | North Shore-Long Island Jewish Health System | Small-molecule modulators of hepatocyte growth factor/scatter factor activities |
| US6610726B2 (en) * | 2001-06-29 | 2003-08-26 | North Shore-Long Island Jewish Research Institute | Compositions and agents for modulating cellular proliferation and angiogenesis |
| WO2004009599A1 (en) | 2002-07-19 | 2004-01-29 | Targacept, Inc. | Five-membered heteroaromatic olefinic azacyclic compounds, pharmaceutical compositions containing them and their use as inhibitors of ncotinic cholinergic receptors |
| US7192976B2 (en) * | 2002-12-21 | 2007-03-20 | Angion Biomedica Corporation | Small molecule modulators of hepatocyte growth factor (scatter factor) activity |
-
2003
- 2003-12-18 US US10/740,708 patent/US7192976B2/en not_active Expired - Lifetime
- 2003-12-19 EP EP03814306.1A patent/EP1572199B1/en not_active Expired - Lifetime
- 2003-12-19 JP JP2004563939A patent/JP5160019B2/ja not_active Expired - Fee Related
- 2003-12-19 EP EP10011181.4A patent/EP2292227B1/en not_active Expired - Lifetime
- 2003-12-19 DK DK10011181.4T patent/DK2292227T3/en active
- 2003-12-19 CN CN2003801095507A patent/CN1747730B/zh not_active Expired - Fee Related
- 2003-12-19 DK DK03814306.1T patent/DK1572199T3/da active
- 2003-12-19 CA CA2511199A patent/CA2511199C/en not_active Expired - Lifetime
- 2003-12-19 AU AU2003301224A patent/AU2003301224C1/en not_active Ceased
- 2003-12-19 HU HUE10011181A patent/HUE030700T2/en unknown
- 2003-12-19 WO PCT/US2003/040917 patent/WO2004058721A2/en not_active Ceased
-
2004
- 2004-12-29 US US11/024,615 patent/US7250437B2/en not_active Expired - Lifetime
- 2004-12-29 US US11/025,373 patent/US7265112B2/en not_active Expired - Lifetime
-
2005
- 2005-06-21 IL IL169316A patent/IL169316A/en active IP Right Grant
-
2007
- 2007-08-13 US US11/891,618 patent/US8580834B2/en not_active Expired - Fee Related
-
2010
- 2010-08-23 JP JP2010186703A patent/JP5755417B2/ja not_active Expired - Fee Related
-
2013
- 2013-10-07 US US14/047,907 patent/US9663471B2/en not_active Expired - Fee Related
-
2015
- 2015-01-30 JP JP2015016424A patent/JP2015078246A/ja active Pending
-
2019
- 2019-01-11 US US16/245,373 patent/US20190382348A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR100345942B1 (ko) | 1-페닐피라졸 화합물 또는 그 광학 이성질체 및 이를 유효 성분으로 함유하는 과요산혈증 및 통풍 치료용 약학 조성물 | |
| KR101629356B1 (ko) | 퀴나졸리논 유도체의 제조방법 | |
| JP2024050527A5 (enExample) | ||
| JP2019034943A5 (enExample) | ||
| JP2022544714A5 (enExample) | ||
| JP2019510787A5 (enExample) | ||
| JP2011527675A5 (enExample) | ||
| JP2006507355A5 (enExample) | ||
| AU2006209543B2 (en) | Six-membered heterocyclic compound and the use thereof | |
| JP2005526138A5 (enExample) | ||
| JP2022552019A5 (enExample) | ||
| JP2022526827A (ja) | （ｅ）－３－［２－（２－チエニル）ビニル］－１ｈ－ピラゾールの固体形態 | |
| JPWO2001036402A1 (ja) | 新規な２−（ｎ−シアノイミノ）チアゾリジン−４−オン誘導体 | |
| US20080025919A1 (en) | Benzoylguanidine salt and hydrates thereof | |
| CN110612286A (zh) | 氰基取代的稠合双环衍生物及其制备方法和用途 | |
| JP2014509297A5 (enExample) | ||
| KR20200123184A (ko) | 증식이상 장애를 치료하기 위한 물질 및 방법 | |
| US7531533B2 (en) | 6-Membered heterocyclic compound and use thereof | |
| JP5538071B2 (ja) | フェニルテトラゾール誘導体を含む骨粗鬆症または肥満の予防または治療用医薬組成物 | |
| US20060241084A1 (en) | Inhibition of vascular endothelial growth factor | |
| JP2798005B2 (ja) | 平滑筋細胞増殖に起因する疾患の治療・予防剤 | |
| JP2021512894A5 (enExample) | ||
| JP2013544833A (ja) | スフィンゴシン−１−リン酸（ｓ１ｐ）受容体モジュレーターとしての新規ピリジン誘導体 | |
| US6730678B2 (en) | Benzoylguanidine salt and hydrates thereof | |
| JP2004123716A (ja) | 化学物質に起因する肝障害の予防及び／又は治療のための医薬 |